Annual Drug Patent Expirations for NEXPLANON Nexplanon is a drug marketed by Organon Usa Inc and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Organon Usa drug NEXPLANON appeared first on DrugPatent…
Annual Drug Patent Expirations for AMZEEQ Amzeeq is a drug marketed by Foamix and is included in one NDA. There are ten patents protecting this drug. AMZEEQ drug price trends.…
The post New patent for Foamix drug AMZEEQ appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for WAKIX Wakix is a drug marketed by Harmony and is included in one NDA. There are five patents protecting this drug. This drug has seventy-two…
The post New patent for Harmony drug WAKIX appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent for Sunovion Pharms drug KYNMOBI appeared first on DrugP…
Annual Drug Patent Expirations for BAQSIMI Baqsimi is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug BAQSIMI appeared first on DrugPatentWatch – Make …
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared first on D…
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fi…
Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on DrugP…
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appear…
New patent for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »